Medical Weight Loss Treatment for New Hampshire Residents
Medically Supervised Weight Loss, Delivered Online
Our providers are licensed by the New Hampshire Board of Medicine to deliver telehealth throughout the Granite State.
Whether you're in Manchester, Concord, or anywhere across New Hampshire — our board-certified providers are ready to see you.
Medical Weight Loss Treatment in New Hampshire
Our board-certified providers prescribe FDA-approved and physician-developed weight loss medications including GLP-1 agonists, customized to your health profile and goals.
No office visits required — 100% online consultations
FDA-approved and physician-developed medications
Personalized dosing protocols adjusted to your response
Ongoing provider support and check-ins throughout treatment
Medications shipped directly to your door from licensed pharmacies
New Hampshire embodies independence—and that includes healthcare choices. From the tech corridor of Manchester to the ski towns of the White Mountains, the seacoast communities to the lakes region, OmniRx Health serves the entire Granite State. Our telehealth platform respects your time and privacy, providing expert care without the need to navigate winter roads or wait in crowded waiting rooms. Live free, live healthy, with convenient virtual care.
Available Treatments in New Hampshire
Our board-certified providers in New Hampshire can prescribe and manage the following treatment options
Semaglutide
Semaglutide is a GLP-1 receptor agonist that reduces appetite and slows gastric emptying, helping patients achieve significant, sustained weight loss. Originally developed for type 2 diabetes management, semaglutide has become one of the most clinically effective weight loss medications available.
Tirzepatide
Tirzepatide is a dual GLP-1 and GIP receptor agonist that produces even greater weight loss than semaglutide alone. It addresses appetite, blood sugar regulation, and metabolic rate through two complementary hormonal pathways for superior outcomes.
Tesofensine
Tesofensine is a triple monoamine reuptake inhibitor that suppresses appetite and boosts metabolism through dopamine, norepinephrine, and serotonin pathways. Originally developed as an anti-Parkinson's agent, it showed exceptional weight loss properties in clinical trials.
Retatrutide
Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).
Telehealth Regulations in New Hampshire
State Licensing
Our providers are licensed by the New Hampshire Board of Medicine to deliver telehealth throughout the Granite State.
Telehealth Law
New Hampshire has telehealth laws that balance provider flexibility with patient protection, supporting virtual care across the state.
Pharmacy Access
New Hampshire pharmacies in Manchester, Nashua, Concord, and northern communities provide prescription services with statewide delivery.
Insurance Notes
New Hampshire insurers cover telehealth services, making virtual care accessible for residents throughout the state.
Frequently Asked Questions
Common questions about medical weight loss and telehealth access in New Hampshire
Explore Related Medical Weight Loss Pages
Direct links to specific treatments and other states.